23. CBD products which satisfy the definition of the CBPM will be Class B controlled medicine and matter to Regulation 16A along with the appropriate constraints for Schedule 2 medication [footnote five]. CBD products which fulfill the definition of a cannabis-centered medication which has been individually scheduled is going to be Class B drugs in